Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    January 2021
  1. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available


  2. ZACHARIAH JP, Shittu T, Wang Y
    Lipid temporal trends in normal-weight youth.
    Am Heart J. 2021;231:68-72.
    PubMed     Abstract available


    April 2020
  3. LOWENSTERN A, Li S, Virani SS, Navar AM, et al
    Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry.
    Am Heart J. 2020;225:88-96.
    PubMed     Abstract available


    February 2020
  4. BOCCARA F, Kumar P, Caramelli B, Calmy A, et al
    Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics.
    Am Heart J. 2020;220:203-212.
    PubMed     Abstract available


    November 2019
  5. LORING Z, Shrader P, Allen LA, Blanco R, et al
    Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.
    Am Heart J. 2019;219:21-30.
    PubMed     Abstract available


    October 2019
  6. CANNON CP, de Lemos JA, Rosenson RS, Ballantyne CM, et al
    Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States.
    Am Heart J. 2019;219:70-77.
    PubMed     Abstract available


  7. CHLEBUS K, Zdrojewski T, Gruchala M, Galaska R, et al
    Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
    Am Heart J. 2019;218:32-45.
    PubMed     Abstract available


    July 2019
  8. OKEKE NL, Webel AR, Bosworth HB, Aifah A, et al
    Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).
    Am Heart J. 2019;216:91-101.
    PubMed     Abstract available


    September 2018
  9. PRADHAN AD, Paynter NP, Everett BM, Glynn RJ, et al
    Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
    Am Heart J. 2018;206:80-93.
    PubMed     Abstract available


    July 2018
  10. PAGIDIPATI NJ, Hellkamp AS, Sharma PP, Wang TY, et al
    High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States.
    Am Heart J. 2018;204:151-155.
    PubMed     Abstract available


    March 2018
  11. TAYLOR BA, Dager AD, Panza GA, Zaleski AL, et al
    The effect of high-dose atorvastatin on neural activity and cognitive function.
    Am Heart J. 2018;197:166-174.
    PubMed     Abstract available


    March 2017
  12. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    PubMed     Abstract available


    November 2016
  13. RERUP SA, Bang LE, Mogensen UM, Engstrom T, et al
    The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
    Am Heart J. 2016;181:35-42.
    PubMed     Abstract available


    August 2016
  14. RIDKER PM, Amarenco P, Brunell R, Glynn RJ, et al
    Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Eve
    Am Heart J. 2016;178:135-44.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: